Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

16th Jun 2020 14:34

PureTech Health PLC - London-based biotherapeutics firm - Founding entity Akili reports US Food & Drug Administration clearance for EndeavorRx to be used in children with ADHD. EndeavorRx is delivered through a video game, the first prescription treatment to do so. Works by improving attention function in children aged between eight and 12.

Current stock price: 260.00 pence

Year-to-date change: down 18%

By Eric Cunha; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

PureTech
FTSE 100 Latest
Value8,809.74
Change53.53